miércoles, 24 de febrero de 2021

Monoclonal antibodies against MERS coronavirus show promise in Phase 1 NIH-sponsored trial | National Institutes of Health (NIH)

Monoclonal antibodies against MERS coronavirus show promise in Phase 1 NIH-sponsored trial | National Institutes of Health (NIH)

No hay comentarios:

Publicar un comentario